Epidemiology of Sarcoidosis: Recent Advances and Future Prospects

ABSTRACT

Sarcoidosis is by definition a disease of “unknown causes,” but recent epidemiologic advances suggest that the long-standing definition of sarcoidosis may soon need to be amended. The recently completed ACCESS (A Case-Control Etiologic Study of Sarcoidosis) study was not able to definitively identify the “cause” of sarcoidosis, but yielded important findings regarding familial and environmental risks that have advanced our understanding of this disease. The HLA-DRB1 associations reported in ACCESS along with the results of two recently completed genome scans of sarcoidosis in German Caucasians and African-Americans, respectively, have further defined the genetics of sarcoidosis. These studies suggest genetic heterogeneity of sarcoidosis risk between Caucasians and African-Americans and multiple susceptibility genes that interact together and with environmental factors in the disease pathogenesis. Genes that influence sarcoidosis clinical phenotypes may also be largely separate from sarcoidosis susceptibility genes. Although genetic studies of sarcoidosis in African-American populations are confounded by Caucasian admixture, this same admixture may be useful in identifying sarcoidosis genes linked with African ancestry. Case-only methods may be useful in identifying recent acute exposures linked to disease, genetic variants of risk, and gene-environment interactions. In summary, the epidemiology of sarcoidosis has a promising future that should eventually provide the answers to the etiologic origins of this complex disease.

KEYWORDS

Sarcoidosis - etiology - epidemiology - genetics - environmental exposure

REFERENCES

• 1 Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999.  Am J Respir Crit Care Med. 1999;  160 736-755
• 2 ACCESS Group . Design of a case control etiologic study of sarcoidosis (ACCESS). ACCESS Research Group.  J Clin Epidemiol. 1999;  52 1173-1186
• 3 Semenzato G. ACCESS: a case control etiologic study of sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2005;  22 83-86
• 4 Rossman M D, Thompson B, Frederick M et al.. HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.  Am J Hum Genet. 2003;  73 720-735
• 5 Rybicki B A, Iannuzzi M C, Frederick M M et al.. Familial aggregation of sarcoidosis: a case-control etiologic study of sarcoidosis (ACCESS).  Am J Respir Crit Care Med. 2001;  164 2085-2091
• 6 Newman L S, Rose C S, Bresnitz E A et al.. A case control etiologic study of sarcoidosis: environmental and occupational risk factors.  Am J Respir Crit Care Med. 2004;  170 1324-1330
• 7 Iannuzzi M C, Maliarik M J, Poisson L M, Rybicki B A. Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African-Americans.  Am J Respir Crit Care Med. 2003;  167 1225-1231
• 8 Valentonyte R, Hampe J, Huse K et al.. Sarcoidosis is associated with a truncating splice site mutation in BTNL2.  Nat Genet. 2005;  37 357-364
• 9 Hizawa N, Yamaguchi E, Furuya K, Jinushi E, Ito A, Kawakami Y. The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population.  Am J Respir Crit Care Med. 1999;  159 2021-2023
• 10 Rybicki B A, Walewski J L, Maliarik M J, Kian H, Iannuzzi M C. The BTNL2 gene and sarcoidosis susceptibility in African-Americans and whites.  Am J Hum Genet. 2005;  77 491-499
• 11 Pandey J P, Frederick M. TNF-alpha, IL1-beta, and immunoglobulin (GM and KM) gene polymorphisms in sarcoidosis.  Hum Immunol. 2002;  63 485-491
• 12 Bogunia-Kubik K, Koscinska K, Suchnicki K, Lange A. HSP70-hom gene single nucleotide ( + 2763 G/A and + 2437 C/T) polymorphisms in sarcoidosis.  Int J Immunogenet. 2006;  33 135-140
• 13 Dubaniewicz A, Jamieson S E, Dubaniewicz-Wybieralska M, Fakiola M, Nancy M E, Blackwell J M. Association between SLC11A1 (formerly NRAMP1) and the risk of sarcoidosis in Poland.  Eur J Hum Genet. 2005;  13 829-834
• 14 Foley P J, Lympany P A, Puscinska E, Zielinski J, Welsh K I, du Bois R M. Analysis of MHC encoded antigen-processing genes TAP1 and TAP2 polymorphisms in sarcoidosis.  Am J Respir Crit Care Med. 1999;  160 1009-1014
• 15 Gazouli M, Koundourakis A, Ikonomopoulos J et al.. CARD15/NOD2, CD14, and Toll-like receptor 4 gene polymorphisms in Greek patients with sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2006;  23 23-29
• 16 Zorzetto M, Bombieri C, Ferrarotti I et al.. Complement receptor 1 gene polymorphisms in sarcoidosis.  Am J Respir Cell Mol Biol. 2002;  27 17-23
• 17 Takada T, Suzuki E, Morohashi K, Gejyo F. Association of single nucleotide polymorphisms in the IL-18 gene with sarcoidosis in a Japanese population.  Tissue Antigens. 2002;  60 36-42
• 18 Akahoshi M, Ishihara M, Remus N et al.. Association between IFNA genotype and the risk of sarcoidosis.  Hum Genet. 2004;  114 503-509
• 19 Morohashi K, Takada T, Omori K, Suzuki E, Gejyo F. Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis.  Chest. 2003;  123 1520-1526
• 20 Rybicki B A, Major M, Popovich J J, Maliarik M J, Iannuzzi M C. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization.  Am J Epidemiol. 1997;  145 234-241
• 21 Yamaguchi M, Hosoda Y, Sasaki R, Aoki K. Epidemiological study on sarcoidosis in Japan: recent trends in incidence and prevalence rates and changes in epidemiological features.  Sarcoidosis. 1989;  6 138-146
• 22 Hillerdal G, Nou E, Osterman K, Schmekel B. Sarcoidosis: epidemiology and prognosis: a 15-year European study.  Am Rev Respir Dis. 1984;  130 29-32
• 23 Henke C E, Henke G, Elveback L R, Beard C M, Ballard D J, Kurland L T. The epidemiology of sarcoidosis in Rochester, Minnesota: a population-based study of incidence and survival.  Am J Epidemiol. 1986;  123 840-845
• 24 Byg K E, Milman N, Hansen S. Sarcoidosis in Denmark 1980-1994: a registry-based incidence study comprising 5536 patients.  Sarcoidosis Vasc Diffuse Lung Dis. 2003;  20 46-52
• 25 Furuya K, Yamaguchi E, Itoh A et al.. Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis.  Thorax. 1996;  51 777-780
• 26 Kruit A, Ruven H J, Grutters J C, Van Den Bosch J M. Angiotensin-converting enzyme 2 (ACE2) haplotypes are associated with pulmonary disease phenotypes in sarcoidosis patients.  Sarcoidosis Vasc Diffuse Lung Dis. 2005;  22 195-203
• 27 Rybicki B A, Kirkey K L, Major M et al.. Familial risk ratio of sarcoidosis in African-American sibs and parents.  Am J Epidemiol. 2001;  153 188-193
• 28 Baughman R P, Teirstein A S, Judson M A et al.. Clinical characteristics of patients in a case control study of sarcoidosis.  Am J Respir Crit Care Med. 2001;  164 1885-1889
• 29 Judson M A, Baughman R P, Thompson B W et al.. Two year prognosis of sarcoidosis: the ACCESS experience.  Sarcoidosis Vasc Diffuse Lung Dis. 2003;  20 204-211
• 30 Terris M, Chavis A D. An epidemiologic study of sarcoidosis.  Am Rev Respir Dis. 1966;  94 50-55
• 31 Buck A A, Sartwell P E. Epidemiologic investigations of sarcoidosis, II: Skin sensitivity and environmental factors.  Am J Hyg. 1961;  74 152-173
• 32 Cummings M M, Hudgins P C. Chemical constituents of pine pollen and their possible relationship to sarcoidosis.  Am J Med Sci. 1958;  236 311-317
• 33 Burdick K H. Cutaneous reaction to pine pollen in sarcoidosis: study of forty cases.  J Invest Dermatol. 1964;  42 449-451
• 34 Gentry J T, Nitowsky H M, Michael Jr M. Studies on the epidemiology of sarcoidosis in the United States: the relationship to soil areas and to urban-rural residence.  J Clin Invest. 1955;  34 1839-1856
• 35 Comstock G W, Keltz H, Sencer J. Clay eating and sarcoidosis: a controlled study in the state of Georgia.  Am Rev Respir Dis. 1961;  84 130-134
• 36 Hurley H J, Close H P, English R S. Soil extracts as antigens in sarcoidosis.  Am Rev Respir Dis. 1962;  86 100-102
• 37 Kajdasz D K, Lackland D T, Mohr L C, Judson M A. A current assessment of rurally linked exposures as potential risk factors for sarcoidosis.  Ann Epidemiol. 2001;  11 111-117
• 38 Drent M, Bomans P H, Van Suylen R J, Lamers R J, Bast A, Wouters E F. Association of man-made mineral fibre exposure and sarcoidlike granulomas.  Respir Med. 2000;  94 815-820
• 39 Rafnsson V, Ingimarsson O, Hjalmarsson I, Gunnarsdottir H. Association between exposure to crystalline silica and risk of sarcoidosis.  Occup Environ Med. 1998;  55 657-660
• 40 Rybicki B A, Amend K L, Maliarik M J, Iannuzzi M C. Photocopier exposure and risk of sarcoidosis in African-American sibs.  Sarcoidosis Vasc Diffuse Lung Dis. 2004;  21 49-55
• 41 Kucera G P, Rybicki B A, Kirkey K L et al.. Occupational risk factors for sarcoidosis in African-American siblings.  Chest. 2003;  123 1527-1535
• 42 Gorham E D, Garland C F, Garland F C, Kaiser K, Travis W D, Centeno J A. Trends and occupational associations in incidence of hospitalized pulmonary sarcoidosis and other lung diseases in navy personnel: a 27-year historical prospective study, 1975-2001.  Chest. 2004;  126 1431-1438
• 43 Barnard J, Rose C, Newman L et al.. Job and industry classifications associated with sarcoidosis in a case-control etiologic study of sarcoidosis (ACCESS).  J Occup Environ Med. 2005;  47 226-234
• 44 Prezant D J, Dhala A, Goldstein A et al.. The incidence, prevalence, and severity of sarcoidosis in New York City firefighters.  Chest. 1999;  116 1183-1193
• 45 Kern D G, Neill M A, Wrenn D S, Varone J C. Investigation of a unique time-space cluster of sarcoidosis in firefighters.  Am Rev Respir Dis. 1993;  148 974-980
• 46 Falkinham III J O. Mycobacterial aerosols and respiratory disease.  Emerg Infect Dis. 2003;  9 763-767
• 47 Fite E, Fernandez-Figueras M T, Prats R, Vaquero M, Morera J. High prevalence of Mycobacterium tuberculosis DNA in biopsies from sarcoidosis patients from Catalonia, Spain.  Respiration. 2006;  73 20-26
• 48 Vokurka M, Lecossier D, du Bois R M et al.. Absence of DNA from mycobacteria of the M. tuberculosis complex in sarcoidosis.  Am J Respir Crit Care Med. 1997;  156 1000-1003
• 49 Brown S T, Brett I, Almenoff P L, Lesser M, Terrin M, Teirstein A S. Recovery of cell wall-deficient organisms from blood does not distinguish between patients with sarcoidosis and control subjects.  Chest. 2003;  123 413-417
• 50 du Bois R M, Goh N, McGrath D, Cullinan P. Is there a role for microorganisms in the pathogenesis of sarcoidosis?.  J Intern Med. 2003;  253 4-17
• 51 Drake W P, Newman L S. Mycobacterial antigens may be important in sarcoidosis pathogenesis.  Curr Opin Pulm Med. 2006;  12 359-363
• 52 Buck A A, McKusick V A. Epidemiologic investigations of sarcoidosis, III: Serum proteins, syphilis, association with tuberculosis: familial aggregation.  Am J Hyg. 1961;  74 174-188
• 53 Headings V E, Weston D, Young R CJ, Hackney R LJ. Familial sarcoidosis with multiple occurrences in eleven families: a possible mechanism of inheritance.  Ann NY Acad Sci. 1976;  278 377-385
• 54 McGrath D S, Daniil Z, Foley P et al.. Epidemiology of familial sarcoidosis in the UK.  Thorax. 2000;  55 751-754
• 55 Schurmann M, Reichel P, Muller-Myhsok B, Schlaak M, Müller-Quernheim J, Schwinger E. Results from a genome-wide search for predisposing genes in sarcoidosis.  Am J Respir Crit Care Med. 2001;  164 840-846
• 56 Rybicki B A, Hirst K, Iyengar S K et al.. A sarcoidosis genetic linkage consortium: the sarcoidosis genetic analysis (SAGA) study.  Sarcoidosis Vasc Diffuse Lung Dis. 2005;  22 115-122
• 57 Haseman J K, Elston R C. The investigation of linkage between a quantitative trait and marker locus.  Behav Genet. 1972;  2 3-19
• 58 Iannuzzi M C, Iyengar S K, Gray-McGuire C et al.. Genome-wide search for sarcoidosis susceptibility genes in African-Americans.  Genes Immun. 2005;  6 509-518
• 59 Gray-McGuire C, Sinha R, Iyengar S et al.. Genetic characterization and fine mapping of susceptibility loci for sarcoidosis in African-Americans on chromosome 5.  Hum Genet. , In press
• 60 Thompson C L, Rybicki B A, Iannuzzi M C et al.. Reduction of sample heterogeneity through use of population substructure: an example from a population of African-American families with sarcoidosis.  Am J Hum Genet. 2006;  79 606-613
• 61 Petrek M, Drabek J, Kolek V et al.. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis.  Am J Respir Crit Care Med. 2000;  162 1000-1003
• 62 Spagnolo P, Renzoni E A, Wells A U et al.. C-C chemokine receptor 2 and sarcoidosis: association with Löfgren's syndrome.  Am J Respir Crit Care Med. 2003;  168 1162-1166
• 63 Valentonyte R, Hampe J, Croucher PJ, et al.. Study of C-C chemokine receptor 2 alleles in sarcoidosis, with emphasis on family based analysis.  Am J Respir Crit Care Med. 2005;  11 1136-1141
• 64 Li Y, Wollnik B, Pabst S et al.. BTNL2 gene variant and sarcoidosis.  Thorax. 2006;  61 273-274
• 65 Brewerton D A, Cockburn C, James D C, James D G, Neville E. HLA antigens in sarcoidosis.  Clin Exp Immunol. 1977;  27 227-229
• 66 Hedfors E, Lindstrom F. HLA-B8/DR3 in sarcoidosis: correlation to acute onset disease with arthritis.  Tissue Antigens. 1983;  22 200-203
• 67 Mrazek F, Holla L I, Hutyrova B et al.. Association of tumour necrosis factor-alpha, lymphotoxin-alpha and HLA-DRB1 gene polymorphisms with Löfgren's syndrome in Czech patients with sarcoidosis.  Tissue Antigens. 2005;  65 163-171
• 68 Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis.  Am J Respir Crit Care Med. 1997;  156 1601-1605
• 69 Swider C, Schnittger L, Bogunia-Kubik K et al.. TNF-alpha and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis.  Eur Cytokine Netw. 1999;  10 143-146
• 70 Sato H, Grutters J C, Pantelidis P et al.. HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis.  Am J Respir Cell Mol Biol. 2002;  27 406-412
• 71 Lofgren S. Erythema nodosum: studies on etiology and pathogenesis in 185 adult cases.  Acta Med Scand. 1946;  124 1-197
• 72 Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients.  Am J Respir Crit Care Med. 2004;  169 696-702
• 73 Martinetti M, Tinelli C, Kolek V et al.. “The sarcoidosis map”: a joint survey of clinical and immunogenetic findings in two European countries.  Am J Respir Crit Care Med. 1995;  152 557-564
• 74 Papadopoulos K I, Melander O, Orho-Melander M, Groop L C, Carlsson M, Hallengren B. Angiotensin converting enzyme (ACE) gene polymorphism in sarcoidosis in relation to associated autoimmune diseases.  J Intern Med. 2000;  247 71-77
• 75 Pietinalho A, Furuya K, Yamaguchi E, Kawakami Y, Selroos O. The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients.  Eur Respir J. 1999;  13 723-726
• 76 Maliarik M J, Rybicki B A, Malvitz E et al.. Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis.  Am J Respir Crit Care Med. 1998;  158 1566-1570
• 77 Niimi T, Tomita H, Sato S et al.. Bronchial responsiveness and angiotensin-converting enzyme gene polymorphism in sarcoidosis patients.  Chest. 1998;  114 495-499
• 78 Ohchi T, Shijubo N, Kawabata I et al.. Polymorphism of Clara cell 10-kD protein gene of sarcoidosis.  Am J Respir Crit Care Med. 2004;  169 180-186
• 79 Janssen R, Sato H, Grutters J C et al.. The Clara cell10 adenine38guanine polymorphism and sarcoidosis susceptibility in Dutch and Japanese subjects.  Am J Respir Crit Care Med. 2004;  170 1185-1187
• 80 Hattori N, Niimi T, Sato S et al.. Cytotoxic T-lymphocyte antigen 4 gene polymorphisms in sarcoidosis patients.  Sarcoidosis Vasc Diffuse Lung Dis. 2005;  22 27-32
• 81 Naruse T K, Matsuzawa Y, Ota M et al.. HLA-DQB1*0601 is primarily associated with the susceptibility to cardiac sarcoidosis.  Tissue Antigens. 2000;  56 52-57
• 82 Voorter C E, Drent M, van den Berg-Loonen E M. Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1*0602-DRB1*150101.  Hum Immunol. 2005;  66 826-835
• 83 Sharma S K, Balamurugan A, Pandey R M, Saha P K, Mehra N K. Human leukocyte antigen-DR alleles influence the clinical course of pulmonary sarcoidosis in Asian Indians.  Am J Respir Cell Mol Biol. 2003;  29 225-231
• 84 Grutters J C, Sato H, Pantelidis P et al.. Analysis of IL6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis.  Sarcoidosis Vasc Diffuse Lung Dis. 2003;  20 20-27
• 85 Abdallah A, Sato H, Grutters J C et al.. Inhibitor kappa B-alpha (IkappaB-alpha) promoter polymorphisms in UK and Dutch sarcoidosis.  Genes Immun. 2003;  4 450-454
• 86 Hill M R, Papafili A, Booth H et al.. Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis.  Am J Respir Crit Care Med. 2006;  174 915-922
• 87 Pabst S, Baumgarten G, Stremmel A et al.. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis.  Clin Exp Immunol. 2006;  143 420-426
• 88 Grutters J C, Sato H, Pantelidis P et al.. Increased frequency of the uncommon tumor necrosis factor -857T allele in British and Dutch patients with sarcoidosis.  Am J Respir Crit Care Med. 2002;  165 1119-1124
• 89 Labunski S, Posern G, Ludwig S, Kundt G, Brocker E B, Kunz M. Tumour necrosis factor-alpha promoter polymorphism in erythema nodosum.  Acta Derm Venereol. 2001;  81 18-21
• 90 Takashige N, Naruse T K, Matsumori A et al.. Genetic polymorphisms at the tumour necrosis factor loci (TNFA and TNFB) in cardiac sarcoidosis.  Tissue Antigens. 1999;  54 191-193
• 91 Seitzer U, Swider C, Stuber F et al.. Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis.  Cytokine. 1997;  9 787-790
• 92 Yamaguchi E, Itoh A, Hizawa N, Kawakami Y. The gene polymorphism of tumor necrosis factor-beta, but not that of tumor necrosis factor-alpha, is associated with the prognosis of sarcoidosis.  Chest. 2001;  119 753-761
• 93 Kreider M E, Christie J D, Thompson B et al.. Relationship of environmental exposures to the clinical phenotype of sarcoidosis.  Chest. 2005;  128 207-215
• 94 Grutters J C, Sato H, Welsh K I, du Bois R M. The importance of sarcoidosis genotype to lung phenotype.  Am J Respir Cell Mol Biol. 2003;  29 S59-S62
• 95 Yamada R, Ymamoto K. Recent findings on genes associated with inflammatory disease.  Mutat Res. 2005;  573 136-151
• 96 Rybicki B A, Sinha R, Iyengar S, Gray-McGuire C, Elston R C, Iannuzzi M C. SAGA Study Consortium . Genetic linkage analysis of sarcoidosis phenotypes: the Sarcoidosis Genetic Analysis (SAGA) Study.  Genet Immun. In press.
• 97 Hills S E, Parkes S A, Baker S B. Epidemiology of sarcoidosis in the Isle of Man, II: Evidence for space-time clustering.  Thorax. 1987;  42 427-430
• 98 Edmondstone W M, Wilson A G. Temporal clustering of familial sarcoidosis in non-consanguineous relatives.  Br J Dis Chest. 1984;  78 184-186
• 99 Visser H, Vos K, Zanelli E et al.. Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors.  Ann Rheum Dis. 2002;  61 499-504
• 100 Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events.  Am J Epidemiol. 1991;  133 144-153
• 101 Wacholder S, Hartge P, Struewing J P et al.. The kin-cohort study for estimating penetrance.  Am J Epidemiol. 1998;  148 623-630
• 102 Saunders C L, Begg C B. Kin-cohort evaluation of relative risks of genetic variants.  Genet Epidemiol. 2003;  24 220-229
• 103 Gail M H, Pee D, Carroll R. Kin-cohort designs for gene characterization.  J Natl Cancer Inst Monogr. 1999;  55-60
• 104 Rybicki B A, Elston R C. The relationship between the sibling recurrence-risk ratio and genotype relative risk.  Am J Hum Genet. 2000;  66 593-604
• 105 Umbach D M, Weinberg C R. Designing and analysing case-control studies to exploit independence of genotype and exposure.  Stat Med. 1997;  16 1731-1743
• 106 Khoury M J, Flanders W D. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls!.  Am J Epidemiol. 1996;  144 207-213
• 107 Albert P S, Ratnasinghe D, Tangrea J, Wacholder S. Limitations of the case-only design for identifying gene-environment interactions.  Am J Epidemiol. 2001;  154 687-693
• 108 Gatto N M, Campbell U B, Rundle A G, Ahsan H. Further development of the case-only design for assessing gene-environment interaction: evaluation of and adjustment for bias.  Int J Epidemiol. 2004;  33 1014-1024
• 109 Gundelfinger B F, Britten S A. Sarcoidosis in the United States Navy.  Am Rev Respir Dis. 1961;  84(suppl) 109-115
• 110 Sartwell P E, Edwards L B. Epidemiology of sarcoidosis in the US Navy.  Am J Epidemiol. 1974;  99 250-257
• 111 Benatar S R. Sarcoidosis in South Africa: a comparative study in whites, blacks and coloureds.  S Afr Med J. 1977;  52 602-606
• 112 Edmondstone W M, Wilson A G. Sarcoidosis in Caucasians, blacks and Asians in London.  Br J Dis Chest. 1985;  79 27-36
• 113 Parra E J, Marcini A, Akey J et al.. Estimating African-American admixture proportions by use of population-specific alleles.  Am J Hum Genet. 1998;  63 1839-1851
• 114 McKeigue P M, Carpenter J R, Parra E J, Shriver M D. Estimation of admixture and detection of linkage in admixed populations by a Bayesian approach: application to African-American populations.  Ann Hum Genet. 2000;  64 171-186
• 115 Smith M W, O'Brien S J. Mapping by admixture linkage disequilibrium: advances, limitations and guidelines.  Nat Rev Genet. 2005;  6 623-632
• 116 Stephens J C, Briscoe D, O'Brien S J. Mapping by admixture linkage disequilibrium in human populations: limits and guidelines.  Am J Hum Genet. 1994;  55 809-824
• 117 Rybicki B A, Iyengar S K, Harris T et al.. The distribution of long range admixture linkage disequilibrium in an African-American population.  Hum Hered. 2002;  53 187-196
• 118 Tian C, Hinds D A, Shigeta R, Kittles R, Ballinger D G, Seldin M FA. Genome-wide SNP panel with high ancestry information for African-American admixture mapping.  Am J Hum Genet. 2006;  79 640-649
• 119 Smith M W, Patterson N, Lautenberger J A et al.. A high-density admixture map for disease gene discovery in African-Americans.  Am J Hum Genet. 2004;  74 1001-1013
• 120 Collins F S, McKusick V A. Implications of the Human Genome Project for medical science.  JAMA. 2001;  285 540-544